Cardinal Health (CAH) Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.

11 equities research analysts have issued 1 year price objectives for Cardinal Health's stock. Their CAH share price forecasts range from $72.00 to $94.00. On average, they anticipate the company's stock price to reach $82.23 in the next twelve months. This suggests that the stock has a possible downside of 1.4%.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.

Cardinal Health's stock was trading at $76.87 at the beginning of 2023. Since then, CAH stock has increased by 8.5% and is now trading at $83.42.
View the best growth stocks for 2023 here.

Cardinal Health saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,640,000 shares, an increase of 13.3% from the April 30th total of 4,980,000 shares. Based on an average daily volume of 2,210,000 shares, the days-to-cover ratio is currently 2.6 days. Approximately 2.2% of the company's stock are short sold.
View Cardinal Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our CAH earnings forecast.

Cardinal Health, Inc. (NYSE:CAH) announced its quarterly earnings data on Thursday, May, 4th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.48 by $0.26. The business had revenue of $50.50 billion for the quarter, compared to analysts' expectations of $49.63 billion. Cardinal Health had a negative trailing twelve-month return on equity of 81.55% and a net margin of 0.23%. The business's quarterly revenue was up 12.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.45 EPS.

Cardinal Health announced a quarterly dividend on Thursday, May 11th. Shareholders of record on Monday, July 3rd will be paid a dividend of $0.5006 per share on Saturday, July 15th. This represents a $2.00 annualized dividend and a yield of 2.40%. The ex-dividend date is Friday, June 30th. This is an increase from the stock's previous quarterly dividend of $0.50.
Read our dividend analysis for CAH.

ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include USCF ESG Dividend Income Fund (UDI), First Trust Nasdaq Pharmaceuticals ETF (FTXH), LeaderShares AlphaFactor Tactical Focused ETF (LSAT), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), SRH U.S. Quality ETF (SRHQ), Alpha Architect U.S. Quantitative Momentum ETF (QMOM), AAM S&P 500 High Dividend Value ETF (SPDV) and SPDR S&P Health Care Services ETF (XHS).

Cardinal Health (NYSE:CAH) pays an annual dividend of $1.98 per share and currently has a dividend yield of 2.44%. The company has been increasing its dividend for 38 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 113.79%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 30.70% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

Cardinal Health updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of $5.60-$5.80 for the period, compared to the consensus EPS estimate of $5.48. The company issued revenue guidance of -.

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.54%), State Street Corp (6.12%), FMR LLC (2.44%), Geode Capital Management LLC (2.12%), Price T Rowe Associates Inc. MD (1.82%) and Arrowstreet Capital Limited Partnership (1.47%). Insiders that own company stock include Michelle Brennan and Ola M Snow.
View institutional ownership trends.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CAH stock can currently be purchased for approximately $83.42.

Cardinal Health (NYSE:CAH) has a market capitalization of $21.24 billion and generates $181.36 billion in revenue each year. The company earns $-933,000,000.00 in net income (profit) each year or $1.74 on an earnings per share basis.

The company employs 46,500 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.